Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Merck
MRK
|
+$362M |
| 2 |
Prologis
PLD
|
+$358M |
| 3 |
NVIDIA
NVDA
|
+$305M |
| 4 |
Corteva
CTVA
|
+$235M |
| 5 |
Atlassian
TEAM
|
+$226M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.8B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$308M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$261M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$259M |
| 5 |
Danaher
DHR
|
+$243M |
Sector Composition
| 1 | Technology | 22.57% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1776
LGI Homes
LGIH
$1.39B
| $6.03M | ﹤0.01% |
65,115
-9,622
| -13% | -$891K |
|
1777
Vital Farms
VITL
$2.17B
| $6.01M | ﹤0.01% |
403,139
+73,829
| +22% | +$1.1M |
|
|
SAGE
1778
DELISTED
Sage Therapeutics
SAGE
| $6.01M | ﹤0.01% |
157,541
-25,502
| -14% | -$973K |
|
1779
Nu Skin
NUS
$596M
| $6M | ﹤0.01% |
142,250
-18,932
| -12% | -$798K |
|
1780
Collegium Pharmaceutical
COLL
$1.18B
| $6M | ﹤0.01% |
258,409
+9,141
| +4% | +$212K |
|
|
OPI
1781
Office Properties Income Trust
OPI
$40.8M
| $5.99M | ﹤0.01% |
448,410
+110,847
| +33% | +$1.48M |
|
1782
Energizer
ENR
$2.02B
| $5.98M | ﹤0.01% |
178,269
-32,959
| -16% | -$1.11M |
|
1783
Pathward Financial
CASH
$1.72B
| $5.96M | ﹤0.01% |
138,530
-61,913
| -31% | -$2.67M |
|
|
VRAY
1784
DELISTED
ViewRay, Inc.
VRAY
| $5.95M | ﹤0.01% |
1,328,531
-162,900
| -11% | -$730K |
|
1785
Autoliv
ALV
$9.68B
| $5.9M | ﹤0.01% |
76,986
+42,561
| +124% | +$3.26M |
|
1786
Transmedics
TMDX
$3.91B
| $5.88M | ﹤0.01% |
95,192
-18,687
| -16% | -$1.15M |
|
1787
B. Riley Financial
RILY
$190M
| $5.84M | ﹤0.01% |
170,756
+26,613
| +18% | +$910K |
|
1788
Geron
GERN
$810M
| $5.83M | ﹤0.01% |
936,484
-79,604
| -8% | -$496K |
|
1789
New Fortress Energy
NFE
$373M
| $5.83M | ﹤0.01% |
137,523
+818
| +0.6% | +$34.7K |
|
1790
Calavo Growers
CVGW
$489M
| $5.82M | ﹤0.01% |
197,940
+12,963
| +7% | +$381K |
|
1791
Celldex Therapeutics
CLDX
$1.62B
| $5.81M | ﹤0.01% |
130,410
-19,236
| -13% | -$857K |
|
1792
Pilgrim's Pride
PPC
$10.4B
| $5.81M | ﹤0.01% |
244,835
-6,429
| -3% | -$153K |
|
1793
Clear Channel Outdoor Holdings
CCO
$651M
| $5.78M | ﹤0.01% |
5,505,194
+607,264
| +12% | +$638K |
|
1794
Pacific Biosciences
PACB
$351M
| $5.77M | ﹤0.01% |
705,107
-167,530
| -19% | -$1.37M |
|
1795
Embecta
EMBC
$878M
| $5.76M | ﹤0.01% |
227,621
+45,133
| +25% | +$1.14M |
|
1796
Immunovant
IMVT
$2.82B
| $5.75M | ﹤0.01% |
323,918
+145,490
| +82% | +$2.58M |
|
1797
Tri Pointe Homes
TPH
$3.09B
| $5.74M | ﹤0.01% |
308,565
-46,222
| -13% | -$859K |
|
1798
Dorman Products
DORM
$4.93B
| $5.73M | ﹤0.01% |
70,866
-4,067
| -5% | -$329K |
|
1799
Hanesbrands
HBI
$2.2B
| $5.73M | ﹤0.01% |
900,774
-176,098
| -16% | -$1.12M |
|
1800
SolarEdge
SEDG
$1.72B
| $5.73M | ﹤0.01% |
20,219
-260
| -1% | -$73.6K |
|